ArticleTherapeutic advances in musculoskeletal disease2023

Rheumatoid arthritis disease activity and adverse events in patients receiving tofacitinib or tumor necrosis factor inhibitors: a

George A Karpouzas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.